Adagene (ADR) (ADAG)
Develops antibody cancer immunotherapies and licenses tumor-activated masking technology.
$2.98
vs last close−0.25 (−7.74%)
Something off on this page? Send us feedback.
EPSReportedEstimate
Mar '24Apr '24Jul '24Mar '25Aug '25Mar '26Apr '26Aug '26
Reported−$0.27−$0.24−$0.31−$0.29−$0.23−$0.11−$0.07−$0.23
Estimate−$0.42−$0.42−$0.41−$0.33−$0.32−$0.19−$0.28−$0.23
Surprise+35.7%+43.5%+24.4%+12.1%+28.1%+42.4%+75.0%0.0%
RevenueReportedEstimate
Mar '24Apr '24Jul '24Mar '25Aug '25Mar '26Apr '26Aug '26
Reported$816.0K——$103.0K—$7.7M$7.7M$1.6M
Estimate——$17.5M$17.5M$17.5M$17.5M—$1.6M
Surprise———−99.4%—−56.0%—+1.3%
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Jun 2029 | −$0.28 | — | — |
| Dec 2028 | −$0.25 | — | — |
| Sep 2028 | −$0.27 | — | — |
| Jun 2028 | −$0.28 | — | — |
| Mar 2028 | −$0.28 | — | — |
| Dec 2027 | −$0.33 | — | — |
| Sep 2027 | −$0.33 | — | — |
| Jun 2027 | −$0.56 | — | — |
| Mar 2027 | −$0.21 | — | — |
| Dec 2026 | −$0.74 | — | — |
| Sep 2026 | −$0.90 | — | — |
| Aug 2026 | −$0.23 | −$0.23 | 0.0% |
| Apr 2026 | −$0.28 | −$0.07 | +75.0% |
| Mar 2026 | −$0.19 | −$0.11 | +42.4% |
| Aug 2025 | −$0.32 | −$0.23 | +28.1% |
| Mar 2025 | |||
| Jul 2024 | |||
| Apr 2024 | |||
| Mar 2024 | |||
| Sep 2023 | |||
| Aug 2023 | |||
| Mar 2023 | |||
| Mar 2023 | |||
| Sep 2022 | |||
| Aug 2022 | |||
| Mar 2022 | |||
| Sep 2021 | |||
| Aug 2021 | |||
| Mar 2021 | |||
| Sep 2020 | |||
| Jun 2020 | |||
| Mar 2020 | |||
| Dec 2019 | |||
| Sep 2019 | |||
| Jun 2019 | |||
| Mar 2019 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Jun 2029 | −$0.28 | — | — | $2.9M | — | — | — |
| Dec 2028 | −$0.25 | — | — | $1.6M | — | — | — |
| Sep 2028 | −$0.27 | — | — | $13.2M | — | — | — |
| Jun 2028 | −$0.28 | — | — | $5.0M | — | — | — |
| Mar 2028 | −$0.28 | — | — | $5.0M | — | — | — |
| Dec 2027 | −$0.33 | — | — | $2.5M | — | — | — |
| Sep 2027 | −$0.33 | — | — | $10.8M | — | — | — |
| Jun 2027 | −$0.56 | — | — | $2.0M | — | — | — |
| Mar 31, 2027 | −$0.21 | — | — | $9.8M | — | — | — |
| Dec 2026 | −$0.74 | — | — | $17.5M | — | — | — |
| Sep 2026 | −$0.90 | — | — | $17.5M | — | — | — |
| Aug 12, 2026 | −$0.23 | −$0.23 | 0.0% | $1.6M | $1.6M | +1.3% | −0.8% |
| Apr 1, 2026 | −$0.28 | −$0.07 | +75.0% | — | $7.7M | — | −13.5% |
| Mar 23, 2026 | −$0.19 | −$0.11 | +42.4% | $17.5M | $7.7M | −56.0% | +8.0% |
| Aug 12, 2025 | −$0.32 | −$0.23 | +28.1% | $17.5M | — | — | −13.6% |
| Mar 24, 2025 | |||||||
| Jul 25, 2024 | |||||||
| Apr 2, 2024 | |||||||
| Mar 29, 2024 | |||||||
| Sep 30, 2023 | |||||||
| Aug 31, 2023 | |||||||
| Mar 31, 2023 | |||||||
| Mar 28, 2023 | |||||||
| Sep 30, 2022 | |||||||
| Aug 30, 2022 | |||||||
| Mar 31, 2022 | |||||||
| Sep 30, 2021 | |||||||
| Aug 26, 2021 | |||||||
| Mar 31, 2021 | |||||||
| Sep 30, 2020 | |||||||
| Jun 30, 2020 | |||||||
| Mar 31, 2020 | |||||||
| Dec 31, 2019 | |||||||
| Sep 30, 2019 | |||||||
| Jun 30, 2019 | |||||||
| Mar 31, 2019 |